CA Stock MarketDetailed Quotes

APS Aptose Biosciences Inc

Watchlist
  • 0.340
  • -0.025-6.85%
15min DelayMarket Closed Dec 27 16:00 ET
20.24MMarket Cap-0.09P/E (TTM)

Aptose Biosciences Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-40.37%6.97M
-49.18%7.35M
-30.76%9.76M
22.90%52.36M
16.57%12.13M
16.51%11.68M
35.41%14.45M
22.57%14.1M
-34.91%42.6M
-57.27%10.4M
Selling and administrative expenses
-33.85%2.26M
-24.13%2.93M
-37.17%3.31M
7.68%15.54M
-16.79%3M
-0.26%3.42M
16.52%3.86M
28.81%5.27M
-25.31%14.43M
-12.10%3.61M
-General and administrative expense
-33.85%2.26M
-24.13%2.93M
-37.17%3.31M
7.68%15.54M
-16.79%3M
-0.26%3.42M
16.52%3.86M
28.81%5.27M
-25.31%14.43M
-12.10%3.61M
Research and development costs
-43.05%4.7M
-58.30%4.41M
-26.85%6.45M
30.89%36.77M
34.53%9.12M
25.51%8.26M
44.15%10.58M
19.18%8.81M
-38.92%28.09M
-66.47%6.78M
Depreciation amortization depletion
-60.00%4K
-58.33%5K
-66.67%6K
-39.51%49K
-55.56%8K
-58.33%10K
-42.86%12K
0.00%18K
-41.30%81K
-47.06%18K
-Depreciation and amortization
-60.00%4K
-58.33%5K
-66.67%6K
-39.51%49K
-55.56%8K
-58.33%10K
-42.86%12K
0.00%18K
-41.30%81K
-47.06%18K
Operating profit
40.37%-6.97M
49.18%-7.35M
30.76%-9.76M
-22.90%-52.36M
-16.57%-12.13M
-16.51%-11.68M
-35.41%-14.45M
-22.57%-14.1M
34.91%-42.6M
57.27%-10.4M
Net non-operating interest income (expenses)
-94.83%12K
-71.47%93K
-71.33%121K
46.07%1.15M
-57.36%171K
-8.66%232K
193.69%326K
1,818.18%422K
738.30%788K
1,722.73%401K
Non-operating interest income
-94.83%12K
-71.47%93K
-71.33%121K
46.07%1.15M
-57.36%171K
-8.66%232K
193.69%326K
1,818.18%422K
738.30%788K
1,722.73%401K
Other net income (expenses)
50.00%-1K
77.78%-2K
-50.00%1K
140.00%2K
0.00%-3K
33.33%-2K
-800.00%-9K
0.00%2K
Gain on sale of security
----
----
50.00%-1K
77.78%-2K
-50.00%1K
140.00%2K
0.00%-3K
33.33%-2K
-800.00%-9K
0.00%2K
Income before tax
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Income tax
Earnings from equity interest net of tax
Net income
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Net income continuous operations
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Noncontrolling interests
Net income attributable to the company
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Diluted earnings per share
78.98%-0.37
81.06%-0.43
67.12%-0.73
-11.47%-7.58
11.66%-1.44
-10.69%-1.76
-31.98%-2.27
-23.33%-2.22
37.90%-6.8
59.75%-1.63
Basic earnings per share
78.98%-0.37
81.06%-0.43
67.12%-0.73
-11.47%-7.58
11.66%-1.44
-10.69%-1.76
-31.98%-2.27
-23.33%-2.22
37.90%-6.8
59.75%-1.63
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -40.37%6.97M-49.18%7.35M-30.76%9.76M22.90%52.36M16.57%12.13M16.51%11.68M35.41%14.45M22.57%14.1M-34.91%42.6M-57.27%10.4M
Selling and administrative expenses -33.85%2.26M-24.13%2.93M-37.17%3.31M7.68%15.54M-16.79%3M-0.26%3.42M16.52%3.86M28.81%5.27M-25.31%14.43M-12.10%3.61M
-General and administrative expense -33.85%2.26M-24.13%2.93M-37.17%3.31M7.68%15.54M-16.79%3M-0.26%3.42M16.52%3.86M28.81%5.27M-25.31%14.43M-12.10%3.61M
Research and development costs -43.05%4.7M-58.30%4.41M-26.85%6.45M30.89%36.77M34.53%9.12M25.51%8.26M44.15%10.58M19.18%8.81M-38.92%28.09M-66.47%6.78M
Depreciation amortization depletion -60.00%4K-58.33%5K-66.67%6K-39.51%49K-55.56%8K-58.33%10K-42.86%12K0.00%18K-41.30%81K-47.06%18K
-Depreciation and amortization -60.00%4K-58.33%5K-66.67%6K-39.51%49K-55.56%8K-58.33%10K-42.86%12K0.00%18K-41.30%81K-47.06%18K
Operating profit 40.37%-6.97M49.18%-7.35M30.76%-9.76M-22.90%-52.36M-16.57%-12.13M-16.51%-11.68M-35.41%-14.45M-22.57%-14.1M34.91%-42.6M57.27%-10.4M
Net non-operating interest income (expenses) -94.83%12K-71.47%93K-71.33%121K46.07%1.15M-57.36%171K-8.66%232K193.69%326K1,818.18%422K738.30%788K1,722.73%401K
Non-operating interest income -94.83%12K-71.47%93K-71.33%121K46.07%1.15M-57.36%171K-8.66%232K193.69%326K1,818.18%422K738.30%788K1,722.73%401K
Other net income (expenses) 50.00%-1K77.78%-2K-50.00%1K140.00%2K0.00%-3K33.33%-2K-800.00%-9K0.00%2K
Gain on sale of security --------50.00%-1K77.78%-2K-50.00%1K140.00%2K0.00%-3K33.33%-2K-800.00%-9K0.00%2K
Income before tax 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Income tax
Earnings from equity interest net of tax
Net income 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Net income continuous operations 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Noncontrolling interests
Net income attributable to the company 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Diluted earnings per share 78.98%-0.3781.06%-0.4367.12%-0.73-11.47%-7.5811.66%-1.44-10.69%-1.76-31.98%-2.27-23.33%-2.2237.90%-6.859.75%-1.63
Basic earnings per share 78.98%-0.3781.06%-0.4367.12%-0.73-11.47%-7.5811.66%-1.44-10.69%-1.76-31.98%-2.27-23.33%-2.2237.90%-6.859.75%-1.63
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.